Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Neurology

Long-Term Safety: Monitoring, Red Flags, and Emergency Planning

At a Glance

For children with SSADHD, long-term safety depends on recognizing prolonged or unusual seizures, sudden behavioral or neurologic changes, and illness-related decline, while keeping a written seizure action plan and coordinating medication and anesthesia decisions with the care team.

Maintaining long-term safety for a child with SSADHD requires a proactive approach to monitoring and a clear plan for emergencies. While many children show improvements in movement and communication over time, the risks associated with epilepsy and behavioral health tend to become more significant as they age [1][2].

Epilepsy Vigilance and Seizure Safety

Epilepsy is a major feature of SSADHD, affecting about half of all patients [2]. Being prepared for the most serious seizure complications is essential.

  • Status Epilepticus: This is a medical emergency where a seizure lasts too long (usually more than 5 minutes) or several seizures occur so close together that the person doesn’t recover in between [3]. In one small study of adults, nearly half had experienced this life-threatening state [3].
  • Nonconvulsive Seizures: Some seizures in SSADHD are not “shaking” events. They may look like prolonged periods of staring or confusion. If your child is unresponsive for a long time, especially before or after a typical seizure, they may be having a nonconvulsive seizure that requires medical evaluation [3][4].
  • SUDEP Risk: Sudden Unexpected Death in Epilepsy (SUDEP) is a rare but serious risk. In one adult registry, SUDEP was reported in about 12% of patients (4 out of 33 adults) [1]. It is critical to understand that this small, selected adult group does not predict the individual risk for a child. Risk factors include uncontrolled tonic-clonic or nocturnal seizures. While strict medication adherence is an important part of risk reduction, it is not a guarantee. You should discuss individualized nocturnal precautions and seizure control with your neurologist [1][3].

Emergency “Red Flags”

Contact your medical team immediately or seek emergency care if you notice any of the following:

  • Prolonged Seizures: Any seizure lasting longer than your child’s typical pattern or longer than 5 minutes.
  • Acute Behavioral Change or Delirium: A sudden onset of extreme confusion, agitation, hallucinations, or “waxing and waning” attention. This can sometimes be triggered by new medications or high doses of sedatives like hydroxyzine [5].
  • Severe Sleep-Wake Disruption: Extreme insomnia combined with agitation or refusal to eat, which can be signs of an underlying metabolic or psychiatric crisis [5].
  • Neurologic Decline During Illness: In rare cases, common illnesses like the flu or bronchiolitis have triggered severe “floppiness” (hypotonia), involuntary movements, or encephalopathy (brain dysfunction) [6].

Procedural Safety and Anesthesia

At some point, your child may need anesthesia for dental work, imaging (like an MRI), or surgery. While anesthesia is generally feasible, it must be carefully planned [7].

  • Individualized Planning: There is no single “unsafe” anesthetic for SSADHD, but children with this condition may respond differently to brain-calming medications.
  • Case Success: One 7-year-old successfully underwent 120 minutes of dental anesthesia using standard medications like sevoflurane and midazolam, with an uncomplicated recovery [7]. However, a single case does not guarantee safety for all patients, ages, or procedures. Always require a pre-procedure plan coordinated between the anesthesiologist, neurologist, and metabolic team. This plan should include medication interaction reviews, seizure-rescue availability, fasting requirements, and postoperative observation tailored to your child [7].

Creating a Safety Net

Because behavioral and seizure issues often change with age, psychiatric monitoring should be a continuous part of your child’s care [8]. A written Seizure Action Plan is the most important tool you can have. This document should be shared with schools and caregivers and should specify:

  1. What a “typical” seizure looks like for your child.
  2. Exactly when to give “rescue” medication (and the correct dose).
  3. When to call 911/emergency services.
  4. Safe practices for higher-risk activities like swimming or bathing. [3][9]

Seizure First Aid: If a seizure occurs, follow these basic steps:

  1. Time the seizure.
  2. Protect the person from injury (move hard objects away).
  3. Place them on their side when safe to help keep the airway clear.
  4. Do NOT restrain them and do NOT put anything in their mouth.
  5. Follow the prescribed rescue-medication plan exactly as written.
  6. Call 911 (or local emergency services) for a first-time seizure, a seizure lasting longer than the plan’s threshold (commonly 5 minutes), repeated seizures without recovery in between, breathing difficulty, or failure to return to baseline.

Common questions in this guide

When should I call emergency services for my child's seizure?
Call emergency services for a first seizure, a seizure lasting longer than the threshold in your child's plan, often 5 minutes, repeated seizures without recovery, breathing trouble, or failure to return to baseline. Time the seizure, protect your child from injury, place them on their side when safe, and do not restrain them or put anything in their mouth. Give rescue medicine exactly as prescribed.
How can a nonconvulsive seizure look in a child with SSADHD?
A nonconvulsive seizure may look like prolonged staring, confusion, or unresponsiveness instead of shaking. Seek medical evaluation if your child remains unresponsive for an unusual length of time, particularly before or after a typical seizure. Anxiety or behavior changes can look similar, so the care team may need to help distinguish them.
What increases the risk of SUDEP in SSADHD?
SUDEP, or sudden unexpected death in epilepsy, is associated with uncontrolled tonic-clonic seizures and seizures during sleep. Discuss seizure control, medication adherence, and individualized nighttime safety measures with your neurologist. These steps may reduce risk but cannot guarantee prevention.
What symptoms should prompt urgent medical attention?
Urgent warning signs include a sudden severe change in behavior or awareness, hallucinations, extreme confusion, severe insomnia with agitation or refusal to eat, or new floppiness, involuntary movements, or brain-function changes during an illness. Contact the medical team promptly or seek emergency care, especially if symptoms are severe, sudden, or accompanied by a seizure or breathing problem. Medication changes or high doses of sedating medicines, such as hydroxyzine, can contribute to some behavior changes, so tell the team what was taken.
How should anesthesia be planned for a child with SSADHD?
Anesthesia can be possible, but it should be planned in advance for the individual child. The anesthesiologist, neurologist, and metabolic team should review medication interactions, fasting, access to rescue medicine, and postoperative observation. A prior uncomplicated procedure does not guarantee the same response for every child or procedure.
What should a seizure action plan include?
It should describe your child's usual seizure, when and how to give rescue medicine, when to call emergency services, and how to keep your child safe during activities such as swimming or bathing. Share the written plan, including the correct dose and emergency contacts, with school staff and all caregivers. Review it as seizure patterns or medicines change.

Get notified when new evidence is published on Succinic semialdehyde dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Age-related phenotype and biomarker changes in SSADH deficiency.

    DiBacco ML, Roullet JB, Kapur K, et al.

    Annals of clinical and translational neurology 2019; (6(1)):114-120 doi:10.1002/acn3.696.

    PMID: 30656189
  2. 2

    The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.

    Tokatly Latzer I, Bertoldi M, DiBacco ML, et al.

    Epilepsia 2023; (64(6)):1516-1526 doi:10.1111/epi.17592.

    PMID: 36961285
  3. 3

    Severe epilepsy phenotypes in adults with succinic semialdehyde dehydrogenase deficiency: Novel clinical and therapeutic insights from an Italian multicenter retrospective cohort study.

    Canafoglia L, Mastrangelo M, Russo M, et al.

    Seizure 2025; (131()):252-256 doi:10.1016/j.seizure.2025.07.018.

    PMID: 40763422
  4. 4

    Natural history of succinic semialdehyde dehydrogenase deficiency through adulthood.

    Lapalme-Remis S, Lewis EC, De Meulemeester C, et al.

    Neurology 2015; (85(10)):861-5 doi:10.1212/WNL.0000000000001906.

    PMID: 26268900
  5. 5

    Hyperactive Delirium Temporally Associated With Hydroxyzine in a Child With Succinic Semialdehyde Dehydrogenase Deficiency Presenting With Psychotic Symptoms: A Case Report.

    Yilanli M, Olexa C, Zapanta B

    Case reports in psychiatry 2026; (2026()):3543154 doi:10.1155/crps/3543154.

    PMID: 42851809
  6. 6

    Acute Infantile Encephalopathy as Presentation of Succinic Semialdehyde Dehydrogenase Deficiency.

    Zeiger WA, Sun LR, Bosemani T, et al.

    Pediatric neurology 2016; (58()):113-5.

    PMID: 27268762
  7. 7

    Anesthetic Management of a Pediatric Patient With Succinic Semialdehyde Dehydrogenase Deficiency Undergoing Dental Procedures.

    Savaş Z

    Case reports in anesthesiology 2025; (2025()):3794766 doi:10.1155/cria/3794766.

    PMID: 41089664
  8. 8

    Establishment and validation of a clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency.

    Tokatly Latzer I, Roullet JB, Gibson KM, Pearl PL

    Journal of inherited metabolic disease 2023; (46(5)):992-1003 doi:10.1002/jimd.12635.

    PMID: 37219411
  9. 9

    Consensus guidelines for the diagnosis and management of succinic semialdehyde dehydrogenase deficiency.

    Tokatly Latzer I, Bertoldi M, Blau N, et al.

    Molecular genetics and metabolism 2024; (142(1)):108363 doi:10.1016/j.ymgme.2024.108363.

    PMID: 38452608

This page provides educational information about long-term SSADHD safety and does not replace medical advice. Ask your child's neurologist and metabolic team for an individualized seizure, medication, illness, and anesthesia plan.